HDEF:NYE-Xtrackers MSCI EAFE High Dividend Yield Equity ETF (USD)

ETF | Foreign Large Value |

Last Closing

USD 27.07

Change

0.00 (0.00)%

Market Cap

USD 1.80B

Volume

0.23M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund will invest at least 80% of its total assets (but typically far more) in component securities of the underlying index. The underlying index is designed to reflect the performance of equities in its parent index, the MSCI EAFE Index, with higher dividend income and quality characteristics than average dividend yields of equities in the parent index, where such higher dividend income and quality characteristics are both sustainable and persistent.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

ETFs Containing HDEF

PRMN Northern Lights Fund Trus.. 14.88 % 0.00 %

N/A

USD 2.22M

Market Performance

  Market Performance vs. Industry/Classification (Foreign Large Value) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.68% 39% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.68% 39% F 55% F
Trailing 12 Months  
Capital Gain 19.83% 72% C 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.83% 72% C 59% D-
Trailing 5 Years  
Capital Gain 19.20% 61% D- 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.20% 61% D- 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 3.93% N/A N/A 52% F
Dividend Return 8.59% N/A N/A 58% F
Total Return 4.66% N/A N/A 77% C+
Risk Return Profile  
Volatility (Standard Deviation) 12.98% N/A N/A 70% C-
Risk Adjusted Return 66.20% N/A N/A 81% B-
Market Capitalization 1.80B 70% C- 65% D

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.